Illumina Named One of Fast Company's Most Innovative Companies for 2022
By:
3BL Media
March 09, 2022 at 05:00 AM EST
Illumina honored for developing several innovative technologies, including COVID-19 sequencing tests to track the spread of variants even at smaller labs
SOURCE: Illumina
DESCRIPTION:
We are honored to have been named one of Fast Company’s Most Innovative Companies for 2022.
A few of our innovative technologies and advancements in 2021 included:
- Introducing the COVIDSeq Assay, which enabled pathogen surveillance in developing countries
- Reaching more than 1 billion covered lives globally for genomic testing
- Launching Illumina Connected Analytics (ICA) to increase the security and privacy of our customers’ data
- Partnering with the Africa CDC and the Bill & Melinda Gates Foundation to help establish an Africa Pathogen Genomics Initiative (APGI)
As an engine of genomics innovation, we understand that the faster we can innovate, the more lives we can impact.
Thank you to our employees, and to the clinicians and researchers we serve, whose passion for the power of genomics made this honor possible.
Learn more about Fast Company's 10 Most Innovative health companies of 2022 here
Learn more about Illumina here
KEYWORDS: illumina, NASDAQ: ILMN, Fast Company 2022 10 Most Influential Health Companies, Illumina Connected Analytics
![]()
More News
View More
MP Materials Stock Soared After Earnings—Here’s the Real Reason ↗
November 22, 2025
Via MarketBeat
Why Palantir Slide May Be a Setup for a Long-Term Opportunity ↗
November 22, 2025
Via MarketBeat
Attention Income Investors: This REIT Is on Sale ↗
November 22, 2025
Rocket Lab Just Had Its First Real Crash—The Rebound Could Be Bigger ↗
November 22, 2025
Via MarketBeat
Tickers
RKLB
MarketBeat Week in Review – 11/17 - 11/21 ↗
November 22, 2025
Recent Quotes
View More
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.
>